|
SUV39H2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62414526272414E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
4.7857273699492E-12 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
6.925400E-01 |
| Stage1-vs-Stage3 |
6.270400E-02 |
| Stage1-vs-Stage4 |
9.740400E-03 |
| Stage2-vs-Stage3 |
8.909700E-02 |
| Stage2-vs-Stage4 |
2.584200E-02 |
| Stage3-vs-Stage4 |
4.505400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
7.61959999984185E-07 |
| Normal-vs-Asian |
1.62436730732907E-12 |
| Caucasian-vs-AfricanAmerican |
1.940250E-01 |
| Caucasian-vs-Asian |
4.928000E-01 |
| AfricanAmerican-vs-Asian |
1.818830E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
2.654600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62625468647093E-12 |
| Normal-vs-Age(81-100Yrs) |
8.08300000000317E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.829010E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.547000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.969600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.786800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.110400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.978800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.322300E-02 |
| Classical-VS-Follicular |
8.566600E-01 |
| Classical-VS-Other |
1.784020E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
3.903600E-02 |
| Tall-VS-Other |
8.401000E-01 |
| Tall-VS-Normal |
1.62481139653892E-12 |
| Follicular-VS-Other |
2.921400E-01 |
| Follicular-VS-Normal |
1.65023550380283E-12 |
| Other-VS-Normal |
3.31600000003096E-06 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
1.091780E-02 |
|
|
